Medicom International Eyetech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 39.74%
(FY 2023)
- Profit -21.93%
(FY 2023)
- Ebitda 2.14%
(FY 2023)
- Net Worth -115.71%
(FY 2023)
- Total Assets 21.47%
(FY 2023)
About Medicom International Eyetech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mukul Bagga and Atul Ajgaonkar serve as directors at the Company.
- CIN/LLPIN
U74999HR2017FTC069824
- Company No.
069824
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
07 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medicom International Eyetech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukul Bagga  | Managing Director | 07-Jul-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Ajgaonkar  | Director | 07-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Medicom International Eyetech.
Medicom International Eyetech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.74% increase. The company also saw a substantial fall in profitability, with a 21.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 115.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicom International Eyetech?
In 2023, Medicom International Eyetech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medicom International Eyetech?
Medicom International Eyetech has a workforce of 15 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicom International Eyetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicom International Eyetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
